- In December 2024, Canon Medical Systems announced new enhancements to its Celesteion PET/CT system, including advanced acquisition and reconstruction techniques. These improvements aim to deliver faster and more accurate imaging for oncology and cardiology applications
- In May 2023, Koninklijke Philips N.V., Elekta, and Mercurius Health announced a 3-year agreement to equip Mercurius Health’s Robert Janker Klinik cancer center in Bonn, Germany. Philips and Elekta will install advanced oncology diagnostic and therapeutic equipment, along with aligned informatics solutions, enhancing cancer care capabilities at the newly acquired facility
- In April 2022, Mediso Ltd. acquired Bartec Technologies Ltd., a UK-based company specializing in Nuclear Medicine and Molecular Imaging equipment. This acquisition aims to bolster Mediso’s presence in the UK and Ireland markets, leveraging Bartec’s expertise in supply, installation, and support of medical imaging technologies
- In June 2022, Siemens Healthineers launched the Symbia Pro.specta, a SPECT/CT system with CE mark and FDA clearance. This advanced system integrates state-of-the-art SPECT and CT imaging technologies, featuring a low-dose CT capable of capturing detailed images with up to 64 slices, enhancing diagnostic accuracy and patient care
- In November 2022, Canon, Inc. announced the establishment of Canon Healthcare USA, INC., a new subsidiary aimed at expanding Canon’s footprint in the American medical market. This strategic move underscores Canon’s commitment to advancing its medical business through enhanced service offerings and innovative healthcare solutions in the U.S.
